ChemicalBook >> CAS DataBase List >>Laprituximab
Laprituximab
- CAS No.
- 1622327-38-1
- Chemical Name:
- Laprituximab
- Synonyms
- Laprituximab;Research Grade Laprituximab;Research Grade Laprituximab (DHB86912)
- CBNumber:
- CB78080977
- Molecular Formula:
- Molecular Weight:
- 0
- MDL Number:
- MOL File:
- Mol file
- MSDS File:
- SDS
- TDS File:
- TDS
Last updated:2026-04-24 14:58:57
| form | Liquid |
|---|---|
| color | Colorless to light yellow |
| FDA UNII | 4CK8OPD3FG |
Laprituximab price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| ChemScene | CS-0628931 | Laprituximab 99.74% | 1622327-38-1 | 1mg | $292 | 2026-06-04 | Buy |
| ChemScene | CS-0628931 | Laprituximab 99.74% | 1622327-38-1 | 5mg | $737 | 2026-06-04 | Buy |
| ChemScene | CS-0628931 | Laprituximab 99.74% | 1622327-38-1 | 10mg | $1170 | 2026-06-04 | Buy |
| aablocks | AA029MXK | Laprituximab >98% | 1622327-38-1 | 1mg | $335 | 2026-06-02 | Buy |
| aablocks | AA029MXK | Laprituximab >98% | 1622327-38-1 | 5mg | $791 | 2026-06-02 | Buy |
Laprituximab Chemical Properties,Uses,Production
Uses
Laprituximab (J2898A) is a humanized IgG1 anti-EGFR antibody that can be used for the synthesis of ADC IMGN289[1].
in vivo
In the H292 xenograft tumor model, the minimally effective doses of Laprituximab (J2898A) is 3 mg/kg[1].
References
[1] Chittenden T D, et al. IMGN289, an EGFR-targeting antibody-maytansinoid conjugate with potent activity against non-small cell lung cancer (NSCLC) regardless of dependency on EGFR pathway. Cancer Research, 2013, 73(8_Supplement): 5467-5467.
Laprituximab Preparation Products And Raw materials
Raw materials
Preparation Products
Laprituximab Suppliers
Global( 15)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| ShangHai Biochempartner Co.,Ltd | 177-54423994 17754423994 | 2853530910@QQ.com | China | 8000 | 62 |
| Wuhan Chemstan Biotechnology Co., Ltd. | 027-65317797 15926423062 | 422450190@qq.com | China | 10305 | 58 |
| Beijing Jin Ming Biotechnology Co., Ltd. | 010-60605840 | psaitong@jm-bio.com | China | 27626 | 58 |
| Biolab Reagents | 027-65279366 18108604356 | products@biolabreagent.com | China | 9864 | 58 |
| Wuhan Jingkangen Biomedical Technology Co., Ltd | 13720134139 086-15871494362 13720134139 | orders@jknbiochem.com | China | 7283 | 58 |
| Shanghai Yifei Biotechnology Co. , Ltd. | 021-65675885 18964387627 | customer_service@efebio.com | China | 11963 | 58 |
| Wuhan Acumen Bio-Technology Co.,ltd | 027-027-16602739303 16602739303 | 673003916@qq.com | China | 4593 | 58 |
| Changsha Fuzhen Biotechnology Co.，LTD | 15111215862 18229892877 | 3062105966@qq.com | China | 5550 | 58 |
| Olix ( Hubei) Pharmaceutical Technology Co., Ltd | 17316404525 17316404525 | 209533805@qq.com | China | 9769 | 58 |
| Atagenix Laboratories | 027-87008169 17762441161 | info@atagenix.com | China | 9997 | 58 |
1622327-38-1(Laprituximab)Related Search:
Laprituximab
Research Grade Laprituximab (DHB86912)
Research Grade Laprituximab
1622327-38-1
